Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct Prognostic and Immunological Roles of ETS1 and ETS2: A Pan-Cancer Analysis. | Biomed Res Int | 2023 | 36760475 | PubTator, text mining | PubMed |
| Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers. | Mol Cancer | 2023 | 36759842 | PubTator, text mining | PubMed |
| The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma. | Front Genet | 2023 | 36755568 | PubTator, text mining | PubMed |
| Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2. | Nat Commun | 2023 | 36755036 | PubTator, text mining | PubMed |
| Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry. | Cancer Metastasis Rev | 2023 | 36754910 | PubTator, text mining | PubMed |
| CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma. | J Pathol Clin Res | 2023 | 36754859 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future. | J Immunother Precis Oncol | 2023 | 36751657 | PubTator, text mining | PubMed |
| Immune Mechanisms in Inflammatory Anemia. | Annu Rev Immunol | 2023 | 36750316 | PubTator, text mining | PubMed |
| Risiko und Häufigkeit von Long-COVID. | CME (Berl) | 2023 | 36747962 | PubTator, text mining | PubMed |
| Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities. | Oncologist | 2023 | 36745503 | PubTator, text mining | PubMed |
| Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives. | Ther Adv Med Oncol | 2023 | 36743524 | PubTator, text mining | PubMed |
| Immune therapy: a new therapy for acute myeloid leukemia. | Blood Sci | 2023 | 36742185 | PubTator, text mining | PubMed |
| Immunotherapies in rare cancers. | Mol Cancer | 2023 | 36726126 | PubTator, text mining | PubMed |
| ASAP─Automated Sonication-Free Acid-Assisted Proteomes─from Cells and FFPE Tissues. | Anal Chem | 2023 | 36724070 | PubTator, text mining | PubMed |
| CAR T cells: engineered immune cells to treat brain cancers and beyond. | Mol Cancer | 2023 | 36721153 | PubTator, text mining | PubMed |
| Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. | Nat Commun | 2023 | 36720864 | PubTator, text mining | PubMed |
| CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. | Mol Cancer | 2023 | 36717905 | PubTator, text mining | PubMed |
| The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma. | Clin Epigenetics | 2023 | 36707882 | PubTator, text mining | PubMed |
| A ferroptosis-related prognostic model with excellent clinical performance based on the exploration of the mechanism of oral squamous cell carcinoma progression. | Sci Rep | 2023 | 36702843 | PubTator, text mining | PubMed |
| Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies. | Curr Treat Options Oncol | 2023 | 36701037 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=46